Shire Makes $30B All-Stock Bid for Drug Maker Baxalta
46:52 - Shire makes a $30B all-stock bid for one month old Baxalta. So what would this deal mean for the industry? Bloomberg Intelligence’s Sam Fazeli discusses the deal on “Countdown.”
Greece Sees Bailout in Sight
Supply vs. Demand: The Perfect Storm in Commodities
Commodities Slide: Should You Brace for the Worst?
Please upgrade your Browser
Your browser is out-of-date. Please download one of these excellent browsers: